Mount Sinai Announces CastleVax Inc., a Clinical-Stage Infectious Diseases Company Developing Novel Vaccines and Therapeutics Targeting Pandemic Threats and Diseases.

Press/Media

Period9 Aug 2022

Media coverage

1

Media coverage

  • TitleMount Sinai Announces CastleVax Inc., a Clinical-Stage Infectious Diseases Company Developing Novel Vaccines and Therapeutics Targeting Pandemic Threats and Diseases.
    Media name/outletPRWeb Newswire
    Country/TerritoryUnited States
    Date9/08/22
    PersonsAdolfo Garcia-Sastre
View all 1
View less